| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |